Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

Featured Articles | Featured Partners | Videos | Industry News | Events

November 14, 2024

Newsletter Sponsor

Is Your Product Compliant With The FDA’s Newest Nitrosamine Guidance?

Nitrosamine contamination in pharmaceutical products has become a critical concern within the industry. The Food & Drug Administration has taken an active role in addressing these concerns, issuing warnings about the risks associated with nitrosamine. New FDA guidance provides a clearer path forward for drug manufacturers. Stay compliant: learn more about established and emerging techniques to reduce nitrosamine formation in your products.

	Industry News

Flashpoint Therapeutics Announces $50M KAIMRC Partnership and Clinical Pipeline Expansion
Flashpoint Therapeutics announced a significant expansion of its therapeutic pipeline through ... read more »

Benuvia Operations and Department of Veterans Affairs Sign CRADA Agreement
Benuvia Operations, an FDA registered, DEA licensed, and cGMP specializing in pharmaceutical ... read more »

Aravax Establishes Pharmaceutical Development Base at the Oxford, UK Science Park
Aravax announced it has established a UK subsidiary, based on the Oxford Science Park, as the ... read more »

Avantor® Opens Bridgewater NJ Innovation Center
Avantor, Inc. announced the opening of its new flagship Bridgewater Innovation Center. The state-of-... read more »

	Featured Video

A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules,... read more »

On-Demand Webinar: The Evolution of Clinical Operations and the Growth of FSP Partnerships
This webinar examines how clinical operations has evolved to overcome study sponsors’ biggest challenges and ensure they continually advance new medicines and medical devices, and how the FSP model ... read more »

	Featured WhitePapers

		Streamlining ADC Development: Advantage of an All-in-One Solution In this whitepaper, our experts delve into challenges of antibody-drug conjugate (ADC) production, in particular the complex logistics and ... read more »

		Overcoming Barriers to Patient Adherence with a Novel Dosage Form To make administration of an effective drug treatment easier for patients with hand tremors or swallowing difficulties, Adare Pharma Solutions ... read more »

	More Services

Clinical Research Services Learn More
Drug Product Manufacturing Learn More
Pharmaceutical Contract Packaging Services Learn More

	Service Directory

Analytical Method Validation Services Search More

Pharmaceutical Contract Lyophilization Services Search More

Pharmaceutical Vial and Aseptic Liquid Filling Services Search More

	Events

AI in Drug Development-Slashing Trial Time and Cost
–
Traditional drug development processes are plagued by exorbitant costs and prolonged timelines, presenting formidable barriers to innovation in the ... event details »

Can GenAI Address the Soaring Costs of Pharma Medical Writing?
–
The pharma industry is rapidly coming to appreciate the substantial scope of Generative AI to transform medical writing, for regulatory documentation,... event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA